Biogen Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€103.25
Target price
22.04.26
€195.75
Performance (%)
1.79%
Price
14:10
€105.10
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 1.79%. This prediction currently runs until 22.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -8.019% | -8.019% |
iShares Core DAX® | 0.200% | 4.061% |
iShares Nasdaq 100 | 1.230% | 5.596% |
iShares Nikkei 225® | 0.348% | 0.896% |
iShares S&P 500 | 0.438% | 4.263% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat